In this group, basic research is developed with a translational approach to identify and characterize the genetic variations of immunoreceptors that regulate innate and / or adaptive immune responses.

The group's research involves defining the molecular basis of certain diseases (especially genetic problems), proposing a better diagnosis and developing strategies for cellular immunotherapy (the use of cells as a treatment) in order to resolve abnormal functioning of patients' immune system. In the case of cancer, the group aims to restore the antitumor response of patients, being able to control and even cure certain tumors. Some of the proposals use gene therapy to improve lymphocyte function, with CART cells being the prime example.

The group is focused on evaluating the anti-inflammatory power of new drugs, knowing the pathophysiology of some clinical problems (asthma, chronic rhinosinusitis, food allergy, urticaria, NSAID intolerance) and the mechanism of action of existing medications (corticosteroids, biological) and new therapies (post-traumatic olfactory training and cell therapy).